公司代码：603020 公司简称：爱普股份 爱普香料集团股份有限公司 第 1页 共 169页 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人魏中浩、主管会计工作负责人冯林霞及会计机构负责人（会计主管人员）冯林 霞声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告所涉及的未来计划、发展战略等前瞻性陈述，不构成公司对投资者的实质承诺，请投 资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 公司已在本报告中详细描述了公司面临的风险，敬请投资者予以关注，具体详见本报告第三 节"管理层讨论与分析"中的有关 ...

2、问：日用香精业务表现亮眼，公司是通过哪些具体 举措实现这一增长的？公司有何长期规划实现这种增 长的可持续性？ 编号：2025-003 | | □特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动类 | □媒体采访 √业绩说明会 | | 别 | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及人 | 线上参与华宝股份 2025 年半年度网上业绩说明会的投 | | 员姓名 | 资者 | | 时间 | 年 月 日（星期五）下午 2025 08 22 15:00-17:00 | | 地点 | "华宝股份投资者关系"微信小程序 董事长：夏利群先生 | | | 董事、总裁：袁肖琴女士 | | 上市公司接待人员 | | | 姓名 | 独立董事：全泽先生、吴昌勇先生、杨锦健先生 | | | 副总裁、董事会秘书：侯晓勤女士 | | | 财务总监：任玉津女士 | | | 1、问：请问公司在食品配料业务上有哪些新的技术突 | | | 破？ | | | 答：尊敬的投资者，您好。公司深度洞察研判市场趋势， | | | 高度重视健康与 ...

Group 1 - The core stock price of COFCO Technology is 5.87 yuan as of August 5, 2025, with an increase of 0.51% compared to the previous trading day [1] - The trading volume on that day was 106,000 hands, with a transaction amount of 62 million yuan [1] - COFCO Technology's main business includes biotechnology, food ingredients, and health products, and it is part of the agriculture, animal husbandry, and fishery industry, registered in Anhui Province [1] Group 2 - The company expects to achieve a net profit of 100 million to 118 million yuan in the first half of 2025, representing a year-on-year growth of 63% to 92% [1] - Data on capital flow indicates a net outflow of 2.1 million yuan on August 5, with a cumulative net outflow of 10.05 million yuan over the past five trading days [1]

Core Viewpoint - Huabao Co., Ltd. experienced a slight decline in stock price, closing at 19.19 yuan on August 5, reflecting a decrease of 0.05% from the previous trading day [1] Company Overview - Huabao Co., Ltd. is primarily engaged in the research, production, and sales of food additives and food ingredients, with applications across the food, beverage, and health product industries [1] - The company operates within the food and beverage sector and also has attributes related to flavoring and plant-based meat concepts [1] Stock Performance - On August 5, the stock opened at 19.29 yuan, reached a high of 19.44 yuan, and a low of 19.15 yuan, with a total trading volume of 20,061 hands and a transaction amount of 39 million yuan [1] - The net outflow of main funds on August 5 was 4.6697 million yuan, with a cumulative net outflow of 11.998 million yuan over the past five trading days [1] - The current total market capitalization of the company is 11.819 billion yuan, with a price-to-earnings ratio of 60.57 times and a price-to-book ratio of 1.73 times [1]

Core Insights - The article emphasizes the significant potential of food biosynthesis technology in addressing global food supply issues, meeting health and nutrition demands, and tackling environmental challenges [1][3]. Group 1: Opportunities in Food Biosynthesis - Food biosynthesis, based on synthetic biology and precision fermentation, can alleviate food supply pressures and provide a solid foundation for green and sustainable food production, driving deep transformation in the food industry [1]. - Countries worldwide are prioritizing the development of food biosynthesis, with Japan and the U.S. implementing strategic plans to promote food innovation, and China highlighting biomanufacturing in its national development strategies [3]. Group 2: Typical Applications of Food Biosynthesis - Key application areas include: 1. New protein sources 2. Oils 3. Starch 4. Food ingredients [4]. Group 3: Challenges in Food Biosynthesis - The design and efficient synthesis of new proteins are critical, requiring research in strain design, fermentation optimization, and food processing to create balanced and digestible alternative proteins [5]. - Establishing pathways for the biosynthesis of functional oils and developing efficient extraction and purification technologies are necessary for advancing new functional oil products [6]. - There is a need for innovative metabolic engineering or enzymatic synthesis pathways for new food functional ingredients to meet rising consumer demands for flavor and health attributes [7]. - Addressing the challenges in the biosynthesis of nutrients like vitamins and amino acids involves optimizing metabolic pathways and developing high-performance cell factories [8]. - Food biosynthesis also faces regulatory and safety challenges, necessitating the evolution of global regulatory frameworks to ensure safety while supporting industry growth [8]. Group 4: Summary and Outlook - The field of biomanufacturing, particularly through synthetic biology and precision fermentation, is entering a period of rapid development, providing essential technological support for addressing food manufacturing challenges [9]. - Significant progress has been made in the biosynthesis of new proteins, oils, starch, food ingredients, and nutrients, but challenges remain in various aspects of research and application [10]. - Future research directions include integrating AI with food biosynthesis technologies to create intelligent cell factories, expanding the range of synthetic products, and enhancing synthesis efficiency [10].

Core Viewpoint - Xianle Health has received approval from the Thailand Board of Investment for establishing a production base in Thailand, focusing on modern technology food production and processing [1] Investment Approval - The Thailand Board of Investment approved Xianle Health's application for investment, allowing the company to engage in food and beverage production, food additives, food ingredients, and dietary supplements manufacturing [1] - The approval includes the use of agricultural by-products or waste as raw materials for production activities, along with corresponding rights and incentives [1] Board Meeting and Funding - On November 28, 2024, the company held its fourth board meeting, where it approved the proposal for establishing a production base in Thailand [1] - The board agreed to use self-owned and self-raised funds totaling no more than $40 million for the investment [1] - The investment will be executed through Xianle Holdings Limited, a wholly-owned subsidiary in Hong Kong, and Xianle Holdings (Asia) Limited, a wholly-owned subsidiary in Singapore, to establish a wholly-owned project company, Xianle Health Technology (Thailand) Co., Ltd. [1]

Group 1: Company Strategy and Vision - The company aims to be a "leader in delicious living," focusing on "green, nutritious, and healthy" missions while strengthening mergers and acquisitions to enhance core capabilities and market presence [2][3] - The company plans to expand into the daily chemical sector, integrating innovative technology and established channels to unlock growth potential [3] Group 2: Research and Development - The company has established a national recognized enterprise technology center and multiple overseas R&D centers, employing 298 R&D personnel, including 79 perfumers, to drive innovation [3][4] - The company emphasizes technological innovation as a key driver for enhancing competitiveness in the flavor and food ingredient sectors [4] Group 3: International Expansion - The company is accelerating its overseas market presence, particularly in Southeast Asia and the Middle East, with a new food technology base in Indonesia set to enhance its international operations [3][4] - The company aims to build a stable overseas market position, focusing on high-growth potential regions [3] Group 4: Profit Improvement Measures - The company plans to leverage technological innovation and global development strategies to enhance operational efficiency and profitability [4] - Strategies include capturing consumer trends, exploring new product markets, and optimizing supply chain management [4] Group 5: Client Base and Market Position - The company has established a diverse client base across various sectors, including partnerships with major brands like Yili and Luckin Coffee [5] - The company’s food ingredient business is a key focus for strategic transformation and growth [5] Group 6: Financial Performance and Future Outlook - The company reported a net loss for 2024 due to goodwill impairment related to edible flavor assets, but aims to enhance its food ingredient business through strategic acquisitions [5] - Future growth will focus on integrating resources across subsidiaries to drive diversification and scale in the food ingredient sector [5][6]

证券代码：603020 证券简称：爱普股份 公告编号：2025-021 爱普香料集团股份有限公司 2025 年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号---行业信息披露 第十 四号---食品制造》的相关规定，现将爱普香料集团股份有限公司(以下简称"公 司")2025 年第一季度主要经营数据（未经审计）公告如下： 一、报告期经营情况 1、按照产品类别分类情况 单位：万元 币种：人民币 | 产品类别 | 2025 年第一季度 | 2024 年第一季度 | 同比变动(%) | | --- | --- | --- | --- | | 香精 | 15,946.00 | 15,324.58 | 4.06 | | 香料 | 3,663.69 | 4,731.35 | -22.57 | | 食品配料 | 40,565.31 | 54,103.62 | -25.02 | | 小计 | 60,175.00 | 74,159.55 | -18.86 | 2、按照销售 ...